https://www.optimumcomms.com/wp-content/uploads/2023/10/Oxolife_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-11-13 08:50:472023-11-13 10:45:54Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
https://www.optimumcomms.com/wp-content/uploads/2023/10/Oxolife_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-11-13 08:50:472023-11-13 10:45:54Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
Pharmaceutical distributor Mawdsleys unveils its expanded third-party logistics (3PL) warehouse in Doncaster – bigger and greener than before
Rt Hon Ed Miliband, Labour MP for Doncaster North and Shadow…

IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
Trial expected to reach the primary endpoint of progression…

Poolbeg Pharma plc – Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg Pharma
Poolbeg team boosted by highly experienced executives with track…

Lytix Biopharma presents third quarter 2023 results
Oslo, 09 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext…

IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:…

Lytix Biopharma presenting at major investor conferences in London and Stockholm in November
Oslo, 8 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext…

Vicore to Present at the Stifel 2023 Healthcare Conference
Stockholm, November 7, 2023 – Vicore Pharma Holding AB…

Futura expands partnership with M8 Pharmaceuticals for remainder of Central and South American region
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the…

Futura Medical – Eroxon Awarded “New Product of the Year, Healthcare” by Boots
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the…

iOnctura to Present Research on Roginolisib and IOA-359 at ASH
Three abstracts accepted by ASH with two poster presentations
Geneva,…

Poolbeg Pharma plc – POLB 001 Data to be Presented at American Society of Hematology Annual Meeting
Potential to address cancer treatment related Cytokine Release…

Vicore Pharma: Interim report July-September 2023
Stockholm, November 2, 2023 – Vicore Pharma Holding AB (STO:…

Mission Therapeutics to Present Abstract at American Society of Nephrology (ASN) Kidney Week 2023
CAMBRIDGE, UK, 2 November 2023 – Mission Therapeutics (“Mission”),…

IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Non-clinical data demonstrate clear impact of immune modulating…

STORM Therapeutics Appoints Marguerite Hutchinson, J.D., as Chief Business Officer
1 November 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM),…

iOnctura announces FDA clearance of IND application for roginolisib, a first-in-class allosteric modulator of PI3Kδ
Roginolisib is in development for solid and hematologic malignancies…

Leucid Bio to Participate in Upcoming Healthcare Conferences
London, UK – 31 October 2023 – Leucid Bio ("Leucid" or the…

Futura Medical Granted Marketing Authorisation for Eroxon® in Mexico
Futura Medical plc (AIM: FUM), the pharmaceutical company developing…

Invizius Announces Appointment of World-Renowned Nephrologist Professor Bernard Canaud to its Clinical Advisory Board
Invizius Limited (“Invizius”), a biotechnology company developing…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York